NCT06790589View on ClinicalTrials.gov

COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2030

Conditions
Advanced Differentiated Thyroid Gland Carcinoma
Interventions
DRUG

Levothyroxine Oral Tablet [Synthroid]

"Round, colour coded, scored tablet debossed with SYNTHROID on one side and potency on the other side."

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER